CME Group Inc. $CME Shares Bought by Rockefeller Capital Management L.P.

Rockefeller Capital Management L.P. boosted its stake in shares of CME Group Inc. (NASDAQ:CME) by 16.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 156,976 shares of the financial services provider’s stock after buying an additional 22,286 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in CME Group were worth $42,867,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Norges Bank acquired a new position in CME Group during the 4th quarter worth about $1,523,241,000. Sanders Capital LLC acquired a new position in CME Group in the 3rd quarter valued at about $1,006,932,000. Strive Asset Management LLC purchased a new stake in CME Group during the third quarter worth about $636,487,000. Victory Capital Management Inc. increased its stake in CME Group by 746.4% during the fourth quarter. Victory Capital Management Inc. now owns 2,049,649 shares of the financial services provider’s stock worth $559,720,000 after purchasing an additional 1,807,491 shares during the period. Finally, Life Cycle Investment Partners Ltd acquired a new stake in shares of CME Group during the fourth quarter worth about $217,656,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME continues to be highlighted as a dividend and value stock, with analysts noting its strong capital returns, electronic trading growth, and global product expansion could support a long-term rebound. Article Title
• Positive Sentiment: One market note said CME may be undervalued after the CEO succession announcement, suggesting the stock could have upside if investors view the leadership transition as orderly. Article Title
• Neutral Sentiment: CME named longtime finance chief Julie Winkler as its next CEO, while Terry Duffy will step into an executive chairman role; the move appears planned and may reduce uncertainty, but it also marks a major leadership change. Article Title
• Neutral Sentiment: The company is also taking legal action against the CFTC over approval of perpetual crypto futures, arguing the products should be treated as swaps rather than futures. The case could affect CME’s role in crypto derivatives, but the financial impact is still uncertain. Article Title
• Negative Sentiment: Goldman Sachs kept a Sell rating on CME and trimmed its price target, citing leadership transition risk and regulatory uncertainty, which may be weighing on sentiment. Article Title

Insider Activity

In other news, CEO Terrence A. Duffy sold 35,000 shares of the stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $298.51, for a total value of $10,447,850.00. Following the transaction, the chief executive officer owned 55,630 shares in the company, valued at approximately $16,606,111.30. This represents a 38.62% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Hilda Harris Piell sold 5,753 shares of the firm’s stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the sale, the insider directly owned 27,702 shares in the company, valued at $8,438,860.26. This trade represents a 17.20% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.30% of the company’s stock.

CME Group Stock Performance

Shares of NASDAQ:CME opened at $246.38 on Monday. CME Group Inc. has a 52 week low of $244.56 and a 52 week high of $329.16. The company’s 50 day moving average is $279.61 and its two-hundred day moving average is $287.27. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The company has a market cap of $89.28 billion, a PE ratio of 21.02, a P/E/G ratio of 2.75 and a beta of 0.21.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.11 by $0.25. The business had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The company’s revenue for the quarter was up 14.5% on a year-over-year basis. During the same period in the previous year, the company earned $2.80 EPS. Equities analysts predict that CME Group Inc. will post 12.28 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be issued a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend is Tuesday, June 9th. CME Group’s payout ratio is 44.37%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on CME shares. TD Cowen dropped their price objective on shares of CME Group from $340.00 to $323.00 and set a “buy” rating for the company in a report on Thursday, April 23rd. Piper Sandler set a $320.00 price target on shares of CME Group in a research report on Wednesday. Weiss Ratings lowered CME Group from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Thursday, June 11th. JPMorgan Chase & Co. increased their price objective on CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a research note on Thursday, April 16th. Finally, Argus reissued a “hold” rating on shares of CME Group in a research note on Wednesday, March 4th. Twelve equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $305.18.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.